1. India Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
Prism Medico & Pharmacy Ltd.

Prism Medico & Pharmacy Ltd.

BBSE:PRISMMEDI
32.89
INR
+1.60
(+5.11%)
-0.64EPS
393.34MMarket Cap
Prism Medico & Pharmacy Ltd.
BSE:PRISMMEDI
(Bombay Stock Exchange)

Recent

price

32.89

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
0.25
0.16
- -
- -
- -
0.43
8.7
34.56
59.88
44.35
27.65
13.92
2.1
4.82
1.04
4.03
1.37
Revenue per Share
-0.62
-0.5
-0.94
-0.25
-0.05
-0.04
-0.36
-0.03
0.61
-0.08
-0.21
-0.61
-0.13
-0.04
-0.08
0.53
-0.64
Basic EPS, GAAP
-0.15
-0.46
-0.71
-0.18
0.04
0.23
- -
- -
-2.03
-7.2
-0.08
-3.92
4.87
-0.01
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
9.95
9.45
8.51
8.26
8.21
52.02
21.24
21.08
21.69
21.53
21.32
20.71
25
24.97
24.89
25.42
- -
Book Value per Share
9.95
9.45
8.51
8.26
8.21
52.02
21.24
21.08
21.69
21.53
21.32
20.71
25
24.97
24.89
25.42
- -
Tangible Book Value per Share
2
2
2
2
2
2
6
6
6
6
6
6
6
6
6
6
6
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
53
210
363
269
168
84
13
29
6
24
9
Sales/Revenue/Turnover
-302.74
-308.47
- -
- -
- -
-84.76
-2.53
0.08
0.21
-0.25
-1.04
-5.91
-8.15
-4.9
-12.77
16.66
-45.9
Operating Margin (%)
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
-1
-2
-1
- -
- -
-2
- -
4
-1
-1
-4
-1
- -
- -
3
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
25.88
- -
Effective Tax Rate (%)
-248.45
-308.57
- -
- -
- -
-9.76
-4.14
-0.09
1.02
-0.19
-0.78
-4.38
-6
-0.73
-7.71
13.03
-46.47
Profit Margin (%)
19
19
17
16
16
36
59
15
31
110
109
123
149
149
148
153
- -
Working Capital
- -
- -
- -
- -
- -
29
30
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
20
19
17
16
16
104
129
128
132
131
129
126
152
151
151
154
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.98
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.1
- -
Return on Capital (%)
-6.02
-5.18
-10.43
-3.03
-0.55
-0.14
-1.88
-0.15
2.85
-0.38
-1
-2.9
-0.55
-0.14
-0.32
2.09
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
14
Market Capitalization
115
153
393

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
155
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
39
- -
Inventories
- -
68
- -
Total Current Liabilities
- -
2
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.43%
3.91%
2.11%
Free Cash Flow
- -
863.38%
-110.3%
Net Income, GAAP
-15.99%
-118.61%
-753.8%
Sales/Revenue/Turnover
661.41%
40.78%
286.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
3
2
1
6
2026
16
5
1
3
24
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.15
0.02
-0.02
0.07
-0.08
2026
1.08
-0.14
-0.02
-0.4
0.53
2027
-0.1
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Jio Financial Services Limited (NSE:JIOFIN)
Business
Prism Medico and Pharmacy Limited (PRISMMEDI.BO), a development-stage company listed on the BSE, engages in the trading, wholesaling and retailing of straw, fodder, animal and poultry feed, cattle feed, fertilizers, nutrients, organic feed, bio-organics, bio-pesticides, bio-fertilizers, seeds and related agricultural products in India; it also deals in pharmaceuticals, antibiotics, drugs, medicines, chemicals, serums, chemical products, pesticides, dyes, soaps, oils, perfumes, cosmetics and patent medicines, including manufacturing, importing, exporting, repacking and distributing nutraceuticals, healthcare products, Ayurveda supplements, medicinal preparations, vaccines, surgical instruments, veterinary medicines and hospital requisites. Founded in 1985 and headquartered in Sirmaur, Himachal Pradesh, with prior operations referenced in Mohali, Punjab, the company originally incorporated as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January 2012. In fiscal year 2022, it altered its Memorandum of Association to expand into pharmaceuticals manufacturing, trading and allied services; recent developments include auditor changes in 2025 with the appointment of Garg Mendiratta & Associates as statutory auditors for FY 2025-26 following the resignation of Harjeet Parvesh due to pre-occupation, alongside Q1 FY2026 unaudited results showing revenue of INR 158.87L and profit of INR 65.73L.